These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29602228)

  • 1. Low serum level of epidermal growth factor in chronic ketamine users.
    Zhang M; He H; Ning Y; Ding Y; Ke X; Wang D; Deng X; Fan N
    Hum Psychopharmacol; 2018 May; 33(3):e2656. PubMed ID: 29602228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers.
    Fan N; Zhang M; Xu K; Ke X; Ding Y; Wang D; Liu Y; Ning Y; Deng X; He H
    Drug Alcohol Depend; 2015 Jul; 152():57-61. PubMed ID: 26003336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Fan N; Luo Y; Xu K; Zhang M; Ke X; Huang X; Ding Y; Wang D; Ning Y; Deng X; He H
    Schizophr Res; 2015 Dec; 169(1-3):10-15. PubMed ID: 26589393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of cognitive impairments in chronic ketamine users.
    Ke X; Ding Y; Xu K; He H; Wang D; Deng X; Zhang X; Zhou Y; Zhou C; Liu Y; Ning Y; Fan N
    Psychiatry Res; 2018 Aug; 266():124-131. PubMed ID: 29864611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers.
    Ke X; Ding Y; Xu K; He H; Zhang M; Wang D; Deng X; Zhang X; Zhou C; Liu Y; Ning Y; Fan N
    Drug Alcohol Depend; 2014 Sep; 142():290-4. PubMed ID: 25064020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users.
    Fan N; Xu K; Ning Y; Rosenheck R; Wang D; Ke X; Ding Y; Sun B; Zhou C; Deng X; Tang W; He H
    Psychiatry Res; 2016 Mar; 237():311-5. PubMed ID: 26805565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
    Ricci V; Martinotti G; Gelfo F; Tonioni F; Caltagirone C; Bria P; Angelucci F
    Psychopharmacology (Berl); 2011 May; 215(1):143-8. PubMed ID: 21161184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairments in poly-drug ketamine users.
    Liang HJ; Lau CG; Tang A; Chan F; Ungvari GS; Tang WK
    Addict Behav; 2013 Nov; 38(11):2661-6. PubMed ID: 23899429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia.
    Cheng WJ; Chen CH; Chen CK; Huang MC; Pietrzak RH; Krystal JH; Xu K
    Schizophr Res; 2018 Sep; 199():313-318. PubMed ID: 29510925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cognitive impairment and depressive symptoms in current ketamine users.
    Tang WK; Liang HJ; Lau CG; Tang A; Ungvari GS
    J Stud Alcohol Drugs; 2013 May; 74(3):460-8. PubMed ID: 23490576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology.
    Zhang X; Xiao W; Chen K; Zhao Y; Ye F; Tang X; Du X
    Sci Rep; 2020 Apr; 10(1):6506. PubMed ID: 32300175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Analysis of Neuronal Nitric Oxide Synthase 1 Gene Polymorphism With Psychopathological Symptoms in Chronic Ketamine Users.
    Chen J; Zhang M; Zhou C; Ding Y; Fan N; He H
    Front Psychiatry; 2020; 11():580771. PubMed ID: 33424660
    [No Abstract]   [Full Text] [Related]  

  • 14. GRIN2B Gene Polymorphism in Chronic Ketamine Users.
    Fan N; An L; Zhang M; He H; Zhou Y; Ou Y
    Am J Addict; 2020 Mar; 29(2):105-110. PubMed ID: 31957106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users.
    Curran HV; Monaghan L
    Addiction; 2001 May; 96(5):749-60. PubMed ID: 11331033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor potentially participates in the mediation of the increased brain-derived neurotrophic factor following chronic ketamine use.
    Yang J; Zhou Z; Yang C
    Psychopharmacology (Berl); 2012 Mar; 220(1):243; author reply 245. PubMed ID: 22009000
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of chronic ketamine use on frontal and medial temporal cognition.
    Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
    Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism.
    Suzuki K; Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suda S; Sugihara G; Matsuzaki H; Sugiyama T; Kawai M; Minabe Y; Takei N; Mori N
    Biol Psychiatry; 2007 Aug; 62(3):267-9. PubMed ID: 17123472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use.
    Cheung RY; Chan SS; Lee JH; Pang AW; Choy KW; Chung TK
    Hong Kong Med J; 2011 Aug; 17(4):267-73. PubMed ID: 21813893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric morbidity in ketamine users attending counselling and youth outreach services.
    Tang WK; Morgan CJ; Lau GC; Liang HJ; Tang A; Ungvari GS
    Subst Abus; 2015; 36(1):67-74. PubMed ID: 25023206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.